Join
Live feed
·
NEWSReleasevia Quantisnow
GoodRx Holdings Inc. logo

Boehringer Ingelheim and GoodRx Team Up to Offer Low-Cost Humira Biosimilar

ByQuantisnow·Wall Street's wire, on your screen.
GDRX· GoodRx Holdings Inc.
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GDRX (GoodRx Holdings Inc.) and more on Quantisnow.

Boehringer Ingelheim and GoodRx Team Up to Offer Low-Cost Humira Biosimilar | Quantisnow